Red day on Friday for Forward Pharma A/S stock after losing 3.44%
(Updated on Dec 02, 2022)
The Forward Pharma A/S stock price fell by -3.44% on the last day (Friday, 2nd Dec 2022) from $2.91 to $2.81. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.45% from a day low at $2.80 to a day high of $2.90. The price has been going up and down for this period, and there has been a -4.75% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 thousand shares and in total, 753 shares were bought and sold for approximately $2.12 thousand.
Here's how to open broker account if you're new to investing.
The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.77 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.58% during the next 3 months and, with a 90% probability hold a price between $2.36 and $2.69 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
FWP Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, November 28, 2022, and so far it has risen 0.357%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Forward Pharma A/S stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.92 and $3.00. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Forward Pharma A/S stock
Forward Pharma A/S finds support from accumulated volume at $2.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0967 between high and low, or 3.45%. For the last week the stock has had daily average volatility of 4.51%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (FWP) For The Upcoming Trading Day Of Monday 5th
For the upcoming trading day on Monday, 5th we expect Forward Pharma A/S to open at $2.84, and during the day (based on 14 day Average True Range), to move between $2.67 and $2.95, which gives a possible trading interval of +/-$0.136 (+/-4.86%) up or down from last closing price. If Forward Pharma A/S takes out the full calculated possible swing range there will be an estimated 9.71% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.80 (0.36%) than the resistance at $2.88 (2.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Forward Pharma A/S stock A Buy?
Forward Pharma A/S holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -1.638 Open Broker AccountSell Candidate Unchanged
Predicted Opening Price for Forward Pharma A/S of Monday, December 5, 2022
The predicted opening price is based on yesterday's movements between high, low, and closing price.
|Fair opening price December 5, 2022||Current price|
Remember To Visit Our YouTube Channel
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
About Forward Pharma A/S
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.... FWP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.